HL
Therapeutic Areas
Viriom Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Elpida® (elsulfavirine) Daily Oral | HIV-1 Infection | Approved |
| Elpida® (elsulfavirine) Weekly Oral | HIV-1 Treatment & Prophylaxis (PrEP/PEP) | Phase 2 |
| Agape® FDC | HIV-1 Infection | Approved |
| Depulfavirine Injectable (DPV) | HIV-1 Infection | Approved |
| Elsulfavirine FDCs (w/ NRTI/INSTI) | HIV-1 Infection | Bioequivalence |
| VM3500 LA Injectable | HIV-1 Infection | Pre-clinical |
| Favipiravir | SARS-CoV-2 Infection | Bioequivalence |